Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs.
The anthracyclines, such as doxorubicin (DXR), are potent anti-cancer drugs but they are limited by their clinical toxicity. The mechanisms involved remain poorly understood partly because of the difficulty in determining sub-cellular drug localisation. Using a novel method utilising the fluorescent...
Κύριοι συγγραφείς: | Ashley, N, Poulton, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2009
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Targeting DNA with Anthracyclines: The Importance of the Sugar Moiety
ανά: Waldemar Priebe
Έκδοση: (2000-03-01) -
Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.
ανά: Ashley, N, κ.ά.
Έκδοση: (2009) -
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
ανά: Junqi Huang, κ.ά.
Έκδοση: (2022-02-01) -
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer
ανά: Craig Davison, κ.ά.
Έκδοση: (2021-04-01) -
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
ανά: Alessandra Murabito, κ.ά.
Έκδοση: (2020-03-01)